Quercetin ameliorates memory impairment by inhibiting abnormal microglial activation in a mouse model of paradoxical sleep deprivation

Biochem Biophys Res Commun. 2022 Dec 3:632:10-16. doi: 10.1016/j.bbrc.2022.09.088. Epub 2022 Sep 27.

Abstract

Paradoxical sleep deprivation (PSD) is prevalent in modern society, and impaired memory is one of its serious consequences. The pathogenic mechanism is still unclear, and the therapeutic strategies for PSD are limited. Here, we found that quercetin treatment ameliorated memory impairments caused by PSD in a dose-dependent manner in an animal model. Quercetin could restore the dynamic changes of the gamma band while the animals performed novel object recognition (NOR) tasks as determined by electroencephalogram analysis. Morphological analysis showed that quercetin, by targeting the hippocampal CA1 region, strikingly ameliorated the overactivation of microglia induced by PSD. Mechanistically, quercetin inhibited the toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and nuclear factor kappa-b (NF-κB) cascade, which is critical for abnormal microglial activation following PSD stress. Our results provided experimental evidence for the therapeutic effects of quercetin on PSD-related memory impairments by suppressing TLR4/MyD88/NF-κB signaling that mediated abnormal microglia activation in the hippocampus.

Keywords: Microglia; Neuroinflammation; Quercetin; Sleep deprivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Memory Disorders* / drug therapy
  • Memory Disorders* / etiology
  • Mice
  • Microglia* / metabolism
  • Myeloid Differentiation Factor 88 / metabolism
  • NF-kappa B / metabolism
  • Quercetin* / pharmacology
  • Quercetin* / therapeutic use
  • Sleep, REM / drug effects
  • Toll-Like Receptor 4 / metabolism

Substances

  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Quercetin
  • Toll-Like Receptor 4